Education
About Us
Working with TipRanks
Follow Us
Bonus Biogroup (IL:BONS)
:BONS
BONS Stock Chart & Stats
Day’s Range― - ―
52-Week Range9.00 - 26.70
Previous CloseN/A
Volume3.65M
Average Volume (3M)2.51M
Market Cap
245.26M
Enterprise Value87.51M
Total Cash (Recent Filing)6.86M
Total Debt (Recent Filing)10.19M
Price to Earnings (P/E)―
Beta0.97
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,167,925,300
10 Day Avg. Volume1,565,412
30 Day Avg. Volume2,512,376
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)2.29
Price to Sales (P/S)0.00
P/FCF Ratio-3.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bonus Biogroup News
PremiumCompany Announcements
Bonus Biogroup Gains FDA Approval for Crucial Phase III ARDS Drug Trial
PremiumCompany Announcements
Court Approves Bonus Biogroup’s Warrant Extension RequestBONS FAQ
What was Bonus Biogroup ’s price range in the past 12 months?
Bonus Biogroup lowest stock price was 9.00 and its highest was 26.70 in the past 12 months.
What is Bonus Biogroup ’s market cap?
Bonus Biogroup ’s market cap is 245.26M.
When is Bonus Biogroup ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bonus Biogroup ’s earnings last quarter?
Bonus Biogroup released its earnings results on Aug 29, 2021. The company reported -1.6 earnings per share for the quarter, missing the consensus estimate of N/A by -1.6.
Is Bonus Biogroup overvalued?
According to Wall Street analysts Bonus Biogroup ’s price is currently Overvalued.
Does Bonus Biogroup pay dividends?
Bonus Biogroup does not currently pay dividends.
What is Bonus Biogroup ’s EPS estimate?
Bonus Biogroup ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bonus Biogroup have?
Bonus Biogroup has 1,167,925,300 shares outstanding.
What happened to Bonus Biogroup ’s price movement after its last earnings report?
Bonus Biogroup reported an EPS of -1.6 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Bonus Biogroup ?
Currently, no hedge funds are holding shares in IL:BONS
Company Description
Bonus Biogroup
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS, as well as other life-threatening acute inflammatory diseases. Its products in pipeline comprise bone augmentation in osteoporosis patients; novel nano-materials for drug delivery; vascularized bone grafts; and soft tissue grafts. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.